Girjesh Kumar

Girjesh Kumar

Active Director Director DIN 02275915
DIN 02275915 First appointment Aug 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Aug 2008
Shareholding value •••• Premium profile

About Girjesh Kumar

Data last updated:

Girjesh Kumar is a Director at Aspasia Lifescience Private Limited (since 2021), Director at Aspasia Healthcare Private Limited (since 2024) and Director at Ablin Pharma Private Limited (since 2016). The companies operate in Pharma, Healthcare and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹9.83 Cr; the largest is Aspasia Lifescience Private Limited at ₹6.91 Cr (FY 2025). Earlier, Girjesh Kumar was an Additional Director at Alisun Pharma Private Limited (2015–2023) and Director at Avancer Labs Private Limited (2008–2023).

DIN 02275915
Primary Designation Director
Industry Pharma
First Appointment 20 Aug 2008
Oldest Company Age 10 yrs
Largest company Aspasia Lifescience Private Limited · ₹6.91 Cr (FY 2025)
Combined revenue ₹9.83 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aspasia Lifescience Private Limited U24230UR2021PTC013186
Director10 Nov 20212021₹6.91 Cr (FY 2025)Active
Aspasia Healthcare Private Limited U24290UR2022PTC013919
Director23 Jul 20242022₹2.92 Cr (FY 2025)Active
Ablin Pharma Private Limited U85100DL2016PTC301273
Director13 Jun 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alisun Pharma Private Limited U24233DL2014PTC265850
Additional Director17 Apr 20152014₹2.88 Cr (FY 2025)Active
Avancer Labs Private Limited U85195DL2008PTC182223
Director20 Aug 20082008₹13.50 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aspasia Lifescience Private Limited
Ablin Pharma Private Limited
Aspasia Healthcare Private Limited
Alisun Pharma Private Limited
Premium access

Shareholding and investment profile for Girjesh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girjesh Kumar

Girjesh Kumar currently holds 3 directorships: Aspasia Lifescience Private Limited (Director, since 10 Nov 2021, revenue ₹6.91 Cr (FY 2025)); Aspasia Healthcare Private Limited (Director, since 23 Jul 2024, revenue ₹2.92 Cr (FY 2025)); Ablin Pharma Private Limited (Director, since 13 Jun 2016).

Girjesh Kumar was first appointed on 20 Aug 2008 as Director at Avancer Labs Private Limited. The most recent appointment on record is 23 Jul 2024 at Aspasia Healthcare Private Limited.

The 2 current companies of Girjesh Kumar that report revenue have a combined latest revenue of ₹9.83 Cr: Aspasia Lifescience Private Limited ₹6.91 Cr (FY 2025); Aspasia Healthcare Private Limited ₹2.92 Cr (FY 2025).

Girjesh Kumar held 2 earlier board appointments: Alisun Pharma Private Limited (Additional Director, 17 Apr 2015 to 09 Aug 2023); Avancer Labs Private Limited (Director, 20 Aug 2008 to 09 Feb 2023).

The current boards of Girjesh Kumar's companies include Rajeev Kumar Singh (Aspasia Lifescience Private Limited), Sumit Patel (Aspasia Healthcare Private Limited), Anil Kumar Gupta (Ablin Pharma Private Limited), Rajani Chaudhary (Ablin Pharma Private Limited), Vijay Pratap Singh (Ablin Pharma Private Limited), Vipin Chandra Jaiswal (Ablin Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available